abrdn plc Sells 52,940 Shares of Integer Holdings Co. (NYSE:ITGR)

abrdn plc reduced its position in Integer Holdings Co. (NYSE:ITGR) by 18.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 240,301 shares of the medical equipment provider’s stock after selling 52,940 shares during the quarter. abrdn plc’s holdings in Integer were worth $32,099,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of ITGR. Contravisory Investment Management Inc. lifted its holdings in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 80 shares in the last quarter. Huntington National Bank raised its stake in shares of Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 268 shares during the period. R Squared Ltd purchased a new stake in shares of Integer in the fourth quarter valued at $44,000. Versant Capital Management Inc grew its holdings in shares of Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 183 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of Integer by 74.1% in the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 278 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on ITGR shares. Piper Sandler reiterated an “overweight” rating and set a $140.00 target price (up from $125.00) on shares of Integer in a report on Friday, October 25th. Citigroup increased their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. Truist Financial increased their target price on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Wells Fargo & Company reiterated an “overweight” rating and set a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. Finally, Benchmark increased their target price on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $146.56.

Integer Stock Up 2.1 %

NYSE:ITGR opened at $142.37 on Thursday. Integer Holdings Co. has a fifty-two week low of $94.56 and a fifty-two week high of $146.36. The stock has a market capitalization of $4.78 billion, a P/E ratio of 43.94, a P/E/G ratio of 1.81 and a beta of 1.13. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The company’s 50-day simple moving average is $137.91 and its 200-day simple moving average is $130.80.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.